Recent Finacing
Recent Raise
Serenex develops small-molecule therapeutics and supportive-care products using a proprietary high-throughput screening platform, advancing Hsp90-inhibitor programs (SNX-5422) and a mucositis candidate (SNX-1012) across oncology and other indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
